Who are Inventiva's investors?

Inventiva's investors include European Investment Bank, Andera Partners, Claret Capital Partners, New Enterprise Associates (NEA), Samsara BioCapital, Sofinnova Partners.

Inventiva

Founded 2012 · 126 employees on LinkedIn · 6 known investors

Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases. The page presents investor relations content including financial results and corporate governance updates.

Biotech Medical Devices

Investors · 6

European Investment Bank✓ verifiedLuxembourg

Andera PartnersParis

Claret Capital PartnersLondon

New Enterprise Associates (NEA)Menlo Park · $200K – $40M

Samsara BioCapitalPalo Alto

Sofinnova PartnersParis · $540K – $27M

Competitors · 1

by search overlap

Sofinnovapartners8 shared keywordsSofinnova Partners is a venture capital and private investment firm that invests across multiple strategies including biotech, digital health, industrial biotechnology, and capital markets. The firm manages multiple specialized investment strategies focused on life sciences and healthcare innovation.

Companies competing with Inventiva for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Inventiva do?: Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases. The page presents investor relations content including financial results and corporate governance updates.
Who are Inventiva's investors?: Inventiva's investors include European Investment Bank, Andera Partners, Claret Capital Partners, New Enterprise Associates (NEA), Samsara BioCapital, Sofinnova Partners.